Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis.
Pancreatic cancer is one of the most lethal cancers. Increasing incidence and mortality indicates that there is still much lacking in detection and management of the disease. This is partly due to a lack of specific symptoms during early stages of the disease. Several growth factor receptors have be...
Main Authors: | Ramadevi Subramani, Rebecca Lopez-Valdez, Arunkumar Arumugam, Sushmita Nandy, Thiyagarajan Boopalan, Rajkumar Lakshmanaswamy |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4014591?pdf=render |
Similar Items
-
Involvement of actin cytoskeletal modifications in the inhibition of triple-negative breast cancer growth and metastasis by nimbolide
by: Arunkumar Arumugam, et al.
Published: (2021-03-01) -
Parity and Short-Term Estradiol Treatment Utilizes Similar Cellular Mechanisms to Confer Protection Against Breast Cancer
by: Arunkumar Arumugam, et al.
Published: (2014-08-01) -
Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2
by: Arunkumar Arumugam, et al.
Published: (2019-01-01) -
A Breast Tissue Protein Expression Profile Contributing to Early Parity-Induced Protection Against Breast Cancer
by: Christina Marie Gutierrez, et al.
Published: (2015-11-01) -
Hyperglycemia enhances the proliferation of non-tumorigenic and malignant mammary epithelial cells through increased leptin/IGF1R signaling and activation of AKT/mTOR.
by: Rebecca Lopez, et al.
Published: (2013-01-01)